BP000254-CYT-113: Recombinant Human TGFβ3, HEK
Source: HEK-derived.
The specific activity was determined by the dose-dependent inhibition of IL-4 induced proliferation of mouse HT-2 cells (BALB/c spleen activated by sheep erythrocytes in the presence of IL-2) and is typically 0.1-0.5 ug/ml.
Purity > 95%, by SDS-PAGE.BP000254-CYT-143: Recombinant Mouse TGFβ3
Source: HEK-derived.
The ED50 as determined by the cell toxicity assay using the WHO Standard 98/608 as a direct comparison is < 0.05 ug/ml corresponding to a specific activity of 20,000,000 Units/mg.
Purity > 98%, by SDS-PAGE.BP000254-CYT-319: Recombinant Human TGFβ3 (207 a.a.)
Source: E. coli-derived.
Applications: ELISA; WB; Inhibition Assays.BP000254-CYT-368: Recombinant Human TGFβ3
Source: E. coli-derived.
The ED50 as determined by the cell toxicity assay using the WHO Standard 98/608 as a direct comparison is < 0.05 ug/ml corresponding to a specific activity of 20 MU/mg.
Purity > 98%, by SDS-PAGE and RP-HPLC.BP000254-CYT-685: Recombinant Human TGFβ3, CHO
Source: Chinese Hamster Ovarian Cells-derived.
The biological activity was determined using cell toxicity assay via HT-2 cells. The ED50 was found to be < 0.05 ug/ml, corresponding to a specific activity of 20,000,000 IU/mg.
Purity > 97%, by SDS-PAGE.